Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRAPPC11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SCIMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | C2orf42 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | WDR5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SVIL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | ESR1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | TRADD | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | TRIP4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
mRNA | ZBTB3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | RIN1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |